Alicia Irurzun-Lafitte
Private Equity Investor bei UCB Ventures (Private Equity)
Profil
Alicia Irurzun-Lafitte joined UCB Ventures in March 2019 as Partner.
Alicia joined from M Ventures, the corporate venture arm of Merck KGaA.
Since 2014, she was instrumental in the closing of multiple new investments in Oncology, Immunology and Fertility areas in the US and Europe for the M Ventures Healthcare fund.
Alicia was also closely involved with the built-up of Merck spin-offs.
While at M Ventures, she served on the Board of Rewind Therapeutics as Director and Artios, iOnctura, Ribometrix, and TocopheRx as Observer.
Prior to ventures, Alicia held roles in global business development at Merck Serono in Geneva and EMD Serono in Boston.
During her time in business development she closed multiple early stage transactions and was involved in strategic corporate development initiatives.
Alicia holds a MSc from Leiden University in Biopharmaceutical Sciences.
She holds a Bachelor in Biomedical Sciences and completed her undergraduate studies between the University Claude Bernard Lyon 1 and Napier Edinburgh University.Alicia is based at the UCB Ventures’ Boston office and she lives in New York.
Aktive Positionen von Alicia Irurzun-Lafitte
Unternehmen | Position | Beginn |
---|---|---|
UCB Ventures (Private Equity)
UCB Ventures (Private Equity) Investment ManagersFinance UCB Ventures is the venture capital arm of UCB SA and was founded in 2016. UCB Ventures is headquartered in Brussels, Belgium with additional offices in Boston, Massachusetts and London, United Kingdom. | Private Equity Investor | - |
Ehemalige bekannte Positionen von Alicia Irurzun-Lafitte
Unternehmen | Position | Ende |
---|---|---|
Merck Ventures (USA) | Private Equity Investor | 06.03.2019 |
TocopheRx, Inc.
TocopheRx, Inc. Medical SpecialtiesHealth Technology TocopheRx, Inc. developed novel therapies for treatment of infertility. The company was founded by Stephen Palmer, Selva Nataraja, and Henry Yu on December 2, 2013 and was headquartered in Gorton, MA. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
TocopheRx, Inc.
TocopheRx, Inc. Medical SpecialtiesHealth Technology TocopheRx, Inc. developed novel therapies for treatment of infertility. The company was founded by Stephen Palmer, Selva Nataraja, and Henry Yu on December 2, 2013 and was headquartered in Gorton, MA. | Health Technology |
UCB Ventures (Private Equity)
UCB Ventures (Private Equity) Investment ManagersFinance UCB Ventures is the venture capital arm of UCB SA and was founded in 2016. UCB Ventures is headquartered in Brussels, Belgium with additional offices in Boston, Massachusetts and London, United Kingdom. | Finance |
Merck Ventures (USA) | Finance |